USPTO 2015–2025 USPTO PatentsView US Corporation

Treace Medical Concepts, Inc.

USPTO PatentsView assignee record - 91 granted patents across 8 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

21.4

Avg claims per patent

+710%

5-year filing velocity

The verdict

Treace holds 91 US patents across 8 technology areas, rank #3,991 of 50,000 tracked assignees.

#3,991
of 50,000 US assignees by volume: Top 16%
by Innovation Score (48.5/100): 21.4
avg claims per patent: +710%
filing velocity, last 5 yrs

Portfolio overview

Treace Medical Concepts, Inc. has been granted 91 US utility patents between 2017 and 2025, placing Treace Medical Concepts, Inc. at rank #3,991 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.4 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Treace Medical Concepts, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Treace sits between Tango Networks, Inc. (91 patents, rank #3,987) and Arizona Board OF Regents, A BODY Corporate OF THE State OF Arizona Acting FOR AND ON Behalf OF Arizona State University (90 patents, rank #3,995) - the closest US assignees by grant volume. The composite Innovation Score of 48.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 81 grants, compared with 10 in the 2015–2019 window, a +710% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Treace Medical Concepts, Inc.'s 21.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Treace Medical Concepts, Inc. against peers pursuing similar technology classes.

Tango Networks

91
TSMC Nanjing

91
Transdermal Biote…

91
Transitions Optic…

91
University of Man…

91
Whirlpool

91
Treace Medical Co… ◀

91
AGC FLAT Glass No…

90
Arizona Board OF…

90

What this shows Treace holds 91 patents at rank #3,991, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Treace

By rank, the assignees closest to #3,991 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Treace's primary technology class.

Treace's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

48 Top 16% higher than 84% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Treace Medical Concepts, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	2.2%
2018	3	3.3%
2019	5	5.5%
2020	11	12.1%
2021	10	11.0%
2022	10	11.0%
2023	13	14.3%
2024	16	17.6%
2025	21	23.1%

Which technologies does Treace Medical Concepts, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 81

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 3

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 3

G06F - ELECTRIC DIGITAL DATA PROCESSING 1

G06Q - INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR 1

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 1

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 1

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 1

Top 8 of 8 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Complex

Velocity Accelerating

Where it ranks

Overall rank by patents

#3,991

Across all tracked assignees

Innovation Score

48.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Treace Medical Concepts, Inc. hold?

Treace Medical Concepts, Inc. holds 91 US granted patents filed between 2017 and 2025, spanning 8 technology areas.

What is Treace Medical Concepts, Inc.'s Innovation Score?

Treace Medical Concepts, Inc. has an Innovation Score of 48.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Treace Medical Concepts, Inc. focus on?

Treace Medical Concepts, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 81 patents. The company has filed patents in 8 CPC subclasses total.

Is Treace Medical Concepts, Inc.'s patent filing rate increasing or decreasing?

Treace Medical Concepts, Inc.'s recent filing velocity is +710% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Treace Medical Concepts, Inc.'s patents?

Treace Medical Concepts, Inc.'s patents average 21.4 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Treace Medical Concepts, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Treace's 91 grants land it in the top 16% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Treace ranks #3,991 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.